33396-29-1CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@@]2(C)CC(C)=C(O2)[C@H](C)[C@@H](O)[C@]1(C)OJFVYXJKGJMUGRG-KJPZRSJGSA-NErythromycin a enol ether is an aminoglycoside.
Warning
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement)
The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.
UsesErythromycin A Enol Ether (Erythromycin EP Impurity E) is an impurity of Erythromycin.
UsesErythromycin A enol ether is a degradation product of erythromycin formed under acidic conditions by C6–OH internal attack on the C9 ketone to produce a cyclic enol ether. The rearrangement results in a loss of antibiotic activity. This single reaction was the prime driver for the development of second and third generation erythromycins. Erythromycin A enol ether is an important standard for stability studies.
Loading…
33396-29-1DTXSID801371991CHEMBL300004CHEBI:184048DefinitionChEBI: Erythromycin a enol ether is an aminoglycoside.